Have you heard of ALL cancer?

Question

And if you have do you know of any survivors?

Answer 1

I think ALL is Acute Lymphoblastic Leukemia.
Here is the site with the best info on Leukemia:
http://www.leukemia-lymphoma.org/hm_lls
Best Wishes

Answer 2

ALL is a form of leukemia. Yes, I know survivors.

Answer 3

I believe survival rates are good for ALL,(acute lymphoblastic leukaemia) You would have to do a search for the country you re in. They are available on the net. I have added a link to a good website for info on ALL.

Answer 4

its not called ALL cancer its just ALL and yes i've heard of it and know many survivors

Disease Information
Leukemias / Lymphomas: Acute Lymphoblastic Leukemia (ALL)

Alternative Names: ALL, acute lymphocytic leukemia, acute lymphoid leukemia
Definition

Acute lymphoblastic leukemia (ALL) is the most common form of childhood cancer. It affects lymphocytes, a type of white blood cells. Leukemic cells accumulate in the bone marrow, replace normal blood cells and spread to other organs including liver, spleen, lymph nodes, central nervous system, kidneys and gonads.
Incidence

In the United States, about 3,000 children each year are found to have acute lymphoblastic leukemia. Peak incidence occurs from 3 to 5 years of age.
Influencing Factors

ALL affects slightly more boys than girls. It occurs more frequently among whites than blacks. Although siblings of leukemic children have a slightly higher risk of developing the disease, the incidence is relatively low (no more than one in 500).
Survival Rates

About 98 to 99 percent of children with newly diagnosed acute lymphoblastic leukemia attain initial complete remissions (absence of detectable leukemic cells by microscopic examination) in four to six weeks. About 80 percent of children can be cured. Patients who remain leukemia-free for 10 years or more can be considered cured.
Treatment Strategies

Chemotherapy is used to kill leukemia cells. All chemotherapy is stopped after two to three years of treatment. Hematopoietic stem cell transplantation is an option for very high-risk cases (e.g., Philadelphia chromosome-positive ALL or slow responders to remission induction therapy) or those who develop an early relapse in the bone marrow.
Current Research

* Research aims to improve treatment outcome by optimizing dosage and scheduling of antileukemic agents based on the individual patient’s leukemic cell genetic features and host normal cell pharmacogenetics characteristics.
* Molecular genetic abnormalities and the measurement of the level of minimal residual leukemia after remission induction therapy are used to help direct the type of treatment. Research on the profile of gene and protein expression in leukemia cells using microarray technology is providing new insights to the genomics of leukemia and the effects of treatment; this research may lead to unique molecular targets for developing new therapies that are more specific and effective. Pharmacogenomic studies are providing new insights to inherited differences in drug response and to individualize treatment.
* Methods are under study to improve the efficacy and safety of stem cell transplantation and to increase the number of potential of donors.

Answer 5

yes i have heard of cancer and there are numerous types of cancer, but sadly the people i knew who had cancer died of it

Answer 6

no that's a new one for me.

Answer 7

No.